Member Info for Globex

More jam tomorrow, it's a very long road TB has been kicking this can down

Very true his point about adjusted EBITDA, although Audioboom isn't a bad for this as THG. Market will always see through attempts to bury bad news so it's short sighted to even try. Far better to lay their cards on the table and be frank about the numbers in the first place. Instead they're in a situation where market has deciphered reality regardless but an element of management distrust has crept in.

Christianmideast I agree with most of what you say, this a true gamechanger.

But for anyone else potentially going through this I would wholeheartedly recommend not necessarily following his example by refusing to be tested - even if it is a 2nd or 3rd time. Could save your life, and the invasive stuff wouldn't be suggested by a doc unless some risk factor had deemed it worthwhile.

It's true current solutions are inadequate and not nearly accurate enough - this is why OBD is so hugely exciting from an investment and healthcare point of view - but until we get mass adoption, better the current mediocre testing regime than no test at all.

Could literally be mumsy.. parroting Moaning jnr lines, that seething contempt for shareholders, and we already know she has a similarly sharp tongue after giving the Times journo an earful!

I think you've hit the nail on the head there ElectricLion. He's let slip before that he lost most of his savings on Rambler, rolled the dice with what's left here and is now left lashing out in a form of projection, after ramping it himself at the highs.

Small sign this might be a proper grown up industry after all with news JP Morgan has started covering miners. https://www.coindesk.com/business/2023/10/11/bitcoin-mining-industry-is-at-a-crucible-moment-jpmorgan-says/

Like the rest of us they don't rate riot either! They like clsk most. Don't like mara (booo).

This volume specifically corresponds with Amati's holding and they've been suddenly exiting a few other small caps in a similar manner. Whether they're distressed or looking to wind down who knows but we can say for sure their funds have been performing woefully, so wouldn't be surprised if they were just looking for liquidity wherever they can find it.

It's true there's a lot of sh*te posted. Rubbish about market makers manipulating or the spread doing something or other as per every other board when all of that is algorithmically driven. Shorters when there are none. Saying no news when the company has literally just announced an accurate blood test for a type of cancer - a biotech holy grail.

Someone even said the share price was stagnating when we've done 300% in a month! You have to laugh really.

Looks likely to be Amati exiting

This SBF clown show is getting a lot of drip drip mainstream coverage, bit of deja vu of this time last year, as well as the wider economic stuff sure that's not helping overall sector malaise.

No matter how underwhelming the share price performance of your preferred miner(s) may have been over the last few months, you can at least take comfort in the fact you didn't invest in $ault

In the last half year report the overall reported deficit had decreased, expectation is that overall trend will accelerate. The MGN scheme by far the biggest remaining overhang, the last triennial valuation probably came a bit too early in rate cycle for them to significantly make headway yet, but way bond market is going next time they'll arguably have decent upper hand in negotiations with trustees.

Why is the Great John Street Hotel still closed? Amazed major shareholders still tolerate these vanity projects.

Now imagine adding into the mix the potentially exponential growth of their latest test, given its universal application. Personally I haven't felt this bullish about a company for a long time.

If sales nearly doubled between April and June I think halving that projection would make sense either. It suggests not that sales peaked in June but a trend of significant growth, even if it's still early days.

US is by far the bigger market anyway, tellingly the US lab is not just up and running but already accredited - commercially it makes sense for that initial push to be in the largest market. Decentralised and fully privatised healthcare means zero barriers to entry. Ultimately I can see this listing on Nasdaq and UK being a secondary part of the story.

It's simply too new, the test has only just been released. Being part of NICE evaluation etc couldn't possibly be this immediate. Worth remembering this is a effectively challenger biotech with a new ground breaking product. Personally I see those steps as future share price catalysts - imagine the reaction when it gets NICE all clear for example.

It's funny how going to the trouble of compiling that list specifically to counteract misinformation like he's posting yet he still tries to argue with me lol. I hope for his sake he is trolling otherwise it could only mean he's stupid.

You must be trolling

Daily Express https://www.express.co.uk/life-style/health/1816053/game-changing-prostate-cancer-test

Daily Mail https://www.dailymail.co.uk/health/article-12564283/New-blood-test-detect-prostate-cancer-available-Britain.html

The Times https://www.thetimes.co.uk/article/oxford-biodynamics-given-boost-by-prostate-cancer-screening-test-qw0n32sss

This Is Money https://www.dailymail.co.uk/health/article-11724915/New-blood-test-93-accurate-spotting-signs-prostate-cancer-study-says.html

+from earlier in year following the company's earlier successful study

Independent https://www.independent.co.uk/news/science/prostate-cancer-blood-test-diagnosis-b2277475.html

ITV News https://www.itv.com/news/2023-02-07/new-blood-test-for-prostate-cancer-is-94-accurate-researchers-say

Evening Standard https://www.standard.co.uk/tech/science/oxford-biodynamics-imperial-college-nhs-prostate-cancer-b1058671.html

It is simply not true to say that mainstream media have not reported on this. See here:

https://www.lse.co.uk/ShareChat.html?ShareTicker=OBD&share=Oxford-Biodyn&thread=06AD4CD1-1F9B-4B14-8E05-463A326B37ED